Form 4: Orthopediatrics Corp. CEO Acquires 90,395 Shares of Common Stock
SEC Form 4 Filing
Orthopediatrics Corp.'s CEO, David R. Bailey, acquired 90,395 shares of common stock on June 11, 2024.
Summary
- On June 11, 2024, David R. Bailey, the President and CEO of Orthopediatrics Corp., acquired 90,395 shares of common stock.
- The acquisition was a direct transaction.
- Following the transaction, Bailey directly owns 229,779 shares of Orthopediatrics Corp. common stock, which includes 149,930 shares of restricted stock awards.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard Form 4 filing indicating insider stock acquisition, which can be seen as a positive sign, but it doesn't provide enough information to strongly influence sentiment.
Positives
- The CEO's acquisition of shares could be interpreted as a positive signal about their confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. Investors often monitor such filings for signals about management's confidence in the company.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase as a positive sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the transaction where David R. Bailey acquired 90,395 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.